UNC Neurology’s Research Center of Excellence for Lewy Body Dementia participated as a study site for a phase 2 clinical trial that met its primary objective of improving cognition in LBD patients who received neflamapimod.
Seven UNC Health hospitals have received the American Heart Association/American Stroke Association’s Get With The Guidelines® – Stroke Gold Plus Quality Achievement Award.
The Division of Neuromuscular Disorders has been designated as a Hereditary Neuropathy Foundation Charcot-Marie-Tooth Center of Excellence.
View a video of the online memorial service held on July 23, 2020, for Associate Professor Daniel I Kaufer, MD.
As part of its “Clinical Practice” series, The New England Journal of Medicine published “Acute Ischemic Stroke” by neurologist William J. Powers, MD, in its July 16, 2020 issue.
Daniel Ian Kaufer, MD, a professor in the department of neurology for 17 years, passed away on July 2 after a brief battle with cancer. Dr. Kaufer was a masterful clinician, prolific researcher, passionate advocate and beloved mentor. A memorial is set for July 23.
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.